RYTM
RYTM
NASDAQ · Biotechnology

Rhythm Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$94.17
-2.06 (-2.14%)
As of May 10, 9:48 PM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 20 91%
Hold 2 9%
Sell 0 0%
Price Target
Analyst Price Target +7.3% upside
Low Target $80.78
Average Target $101.09
High Target $123.16
Current Price $94.17
Current
$94.17
Target
$101.09
$80.78 $101.09 avg $123.16
Scenario Analysis
Bear Case
$80.78
-14.2%
Low target
Base Case
$101.09
+7.3%
Avg target
Bull Case
$123.16
+30.8%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$122.20
-22.9% from high
52-Week Low
$55.31
+70.3% from low
50-Day SMA
$105.86
-11.0% vs SMA
200-Day SMA
$92.90
+1.4% vs SMA
RSI (14)
49.1
Neutral
Target vs 52W High
$101.09
-17.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%